PCSA — PROCESSA PHARMACEUTICALS INC

Ownership history in UBS Group AG  ·  6 quarters on record

This page tracks every 13F SEC filing in which UBS Group AG reported a position in PROCESSA PHARMACEUTICALS INC (PCSA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 12,640 -51,972 -80.4% 0.00% $36K $2.88
2025 Q2 ADDED 64,612 +64,556 +115278.6% 0.00% $13K $5.12
2025 Q1 REDUCED 56 -7,852 -99.3% 0.00% $21 $9.25
2024 Q4 ADDED 7,908 +7,387 +1417.9% 0.00% $7K $22.10
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PCSA price (monthly, adj. close)

Other funds also holding PCSA

As of 2025 Q4 — sorted by position size

Stonepine Capital Management, LLC 3Y 7Y 0.03% HRT FINANCIAL LP 3Y 7Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% JANE STREET GROUP, LLC 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% VANGUARD GROUP INC 3Y 7Y 0.0% JONES FINANCIAL COMPANIES LLLP 3Y 7Y 0.0% BANK OF AMERICA CORP /DE/ 3Y 7Y 0.0% WELLS FARGO & COMPANY/MN 3Y 7Y 0.0%
← Back to UBS Group AG Holdings